How Can We Help?

Gadolinium

Due to its versatility and ability to pick up on a variety of issues, magnetic resonance imaging (MRI) is one of the most common forms of diagnosing injuries and medical conditions. For many, the MRI process is quick and painless, albeit nerve-wracking. For some, however, a simple procedure administered in preparation for an MRI can lead to a litany of health issues, both immediately after the procedure and long-term.

Gadolinium and its Effects

A significant portion of patients who undergo an MRI do so after being injected with a contrast agent. The purpose of this agent is to enhance the quality of the images resulting from the procedure.

Gadolinium is a heavy metal which has been most commonly used in MRI contrast dyes for several decades. While the use of gadolinium-based contrast agents (GBCAs) is helpful in terms of enhancing the readability of these images, its use does not always come without issue. New studies have shown that the element does not exit the body as quickly as drug manufacturers had anticipated, leading to retention of the metal in the body.

In some cases, those who have undergone MRIs using a gadolinium contrast agent have suffered from gadolinium deposition disease, which can produce devastating health effects. Victims of Gadolinium deposition disease have reported symptoms including:

  • Headaches which won’t go away;
  • Painful and shortened muscles and tendons;
  • Chronic bone and joint pain;
  • Brain fog;
  • Skin thickening;
  • Pins and needle sensation; and
  • Pain in the arms and legs.

Gadolinium deposition disease isn’t the only illness that a victim of gadolinium retention can suffer–in severe circumstances, gadolinium can result in Nephrogenic Systemic Fibrosis (NSF). This disease, which is caused by kidney issues, can lead to:

  • Internal scarring to organs;
  • Darkened and/or reddened skin;  
  • Muscle weakness;
  • Chronic pain in bones and joints;
  • Stiffness in extremities; and
  • Hardened skin.

In some cases, NSF can prove to be fatal, as the victim’s damaged kidneys are unable to rid the body of the gadolinium deposits.

Since the discovery of the potential link between these medical conditions and gadolinium, the Food and Drug Administration (FDA) has issued a safety warning that GBCAs cause the retention of the metal in the body. GBCAs are also required to carry a warning stating that the element is retained in the body following its injection.

Compensation

If you have undergone an MRI which involved the injection of a contrast agent containing gadolinium and have experienced adverse effects from the contrast agent, you may be eligible to receive compensation for the suffering you have experienced. Those suffering from the effects of gadolinium retention may be able to recover compensation for:

  • Medical bills, hospital stays, and other treatment incurred in treating the diseases;
  • Physical pain suffered due to the bone and joint pain that gadolinium retention can cause; and
  • Mental and emotional anguish experienced as a result of the conditions suffered.
  • FREE CASE EVALUATION

  • This field is for validation purposes and should be left unchanged.

Don’t Wait Until It’s Too Late--We’re on Your Side

If you are suffering health problems after undergoing an MRI using gadolinium contrast and need legal assistance, Hughes & Coleman’s team of personal injury attorneys are standing by to help. Don’t wait another second to obtain the help you deserve–to speak with an attorney about your case, submit an online case evaluation form or call (800) 800-4600 today.

Request My Free Consultation

  • This field is for validation purposes and should be left unchanged.